Pharmaceutical

Coherus acquires immuno-oncology company Surface

Coherus BioSciences has concluded the acquisition of immuno-oncology (I-O) company Surface Oncology in a deal totalling nearly $66.9m.

Sep 11, 2023 - 20:00
Coherus acquires immuno-oncology company Surface
Coherus BioSciences has concluded the acquisition of immuno-oncology (I-O) company Surface Oncology in a deal totalling nearly $66.9m.
Read the original article

Tags:

Previous Article

Signal: Kroger to pay up to $1.4bn to settle opioid crisis lawsuits

Next Article

Grit Biotechnology secures funds for development of pipeline programmes

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Tavros and OpenBench expand small molecule drug discovery alliance

Tavros and OpenBench expand small molecule drug discove...

Apr 28, 2023

How a supplement company became a haven for health misinformation

How a supplement company became a haven for health misi...

Sep 8, 2023

National panel dismisses calls for broader suicide risk screening

National panel dismisses calls for broader suicide risk...

Jun 20, 2023